#United States #New York #KZR #CNTA #AFBI

Shareholder Alert: Investigation Into Recent Mergers

The M&A Class Action Firm, led by attorney Juan Monteverde, is making headlines as it investigates several notable mergers involving biotech and pharmaceutical firms. According to reports, the firm has successfully recovered millions for shareholders and is regarded as one of the top firms in its sector, ranking within the Top 50 in the 2025 ISS Securities Class Action Services Report.

Companies Under Investigation

Kezar Life Sciences, Inc. (NASDAQ: KZR)

This company is currently involved in a proposed transaction to sell itself to Aurinia Pharmaceuticals. Under the terms of the deal, shareholders of Kezar are expected to receive $6.955 per share in cash, alongside a non-transferable contingent value right. This investigation aims to ensure that shareholders are fully represented in this transaction.

Centessa Pharmaceuticals plc (NASDAQ: CNTA)

Centessa is also in the spotlight due to its impending sale to Eli Lilly and Company. Shareholders of Centessa can anticipate receiving $38.00 per share in cash and a contingent value right potentially worth up to $9.00 based on the achievement of key milestones. Monteverde & Associates is urging shareholders to consider their rights regarding the transaction.

Affinity Bancshares, Inc. (NASDAQ: AFBI)

Affinity's merger with Fidelity Bancshares (N.C.) promises to deliver $23.00 per share in cash to its shareholders. The firm is investigating whether this offer adequately reflects the fair value of shareholders’ stakes and is conducting outreach exclusively for concerned investors.

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS)

Lastly, Apellis is set to merge with Biogen Inc. In this intricate deal, shareholders can expect to receive $41.00 per share, along with contingent rights contingent upon certain sales thresholds being met for its product, SYFOVRE. The class action firm is dedicated to ensuring the transaction is favorable for shareholders.

Role of Monteverde & Associates

Monteverde & Associates PC prides itself on its proven track record, frequently winning settlements for affected shareholders through both trial and appellate courts, including the U.S. Supreme Court. They emphasize that no corporation, officer, or director operates above the law and advocate for shareholders to voice their concerns.

If you are a shareholder in any of the aforementioned companies and feel you may have been treated unfairly in these transactions, the class action firm encourages you to engage with them. They are currently offering free consultations with no obligation.

To learn more about these investigations or to connect with the firm, visit their website or call the contact number provided in the official announcements. The firm operates out of the iconic Empire State Building in New York City, underscoring their national presence in class action securities litigation.

In conclusion, the ongoing investigations underscore the importance of shareholder advocacy in corporate mergers.

Contact Information

For any questions or further inquiries, reach out to Juan Monteverde at Monteverde & Associates PC via email at [email protected] or by phone at (212) 971-1341. They are available to assist you in navigating your rights as a shareholder during these significant corporate transitions.